Loading
Latest filing published 03 Apr 2026 for 강스템바이오텍.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
강경선, listed as chief executive, appears in our data through filings on 강스템바이오텍 shares, published by DART (FSS). Over a trading history stretching from 2 July 2025 to 30 March 2026, the count stands at 6 filings.
Market trades split into 3 purchases and 1 sale. The totals do not cover 4 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.
The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 3 April 2026 with an open-market purchase in 강스템바이오텍. The median gap between a trade and its publication by DART (FSS) is 5 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations